Article
Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients.
PloS one - 1 Jan 2017
Blazer Ashira, Wang Binhuan, Simpson Danny, Kirchhoff Tomas, Heffron Sean, Clancy Robert M, Heguy Adriana, Ray Karina, Snuderl Matija, Buyon Jill P
Abstract excerpt
OBJECTIVE: Atherosclerosis is exaggerated in African American (AA) systemic lupus erythematosus (SLE) patients, with doubled cardiovascular disease (CVD) risk compared to White patients. The extent to which common Apolipoprotein L1 (APOL1) risk alleles (RA) contribute to this trend is unknown. This retrospective cohort study assessed prevalent atherosclerotic disease across APOL1 genotypes in AA SLE patients....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
